Oligomer-corticosteroid conjugates
The invention provides corticosteroids that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the corticosteroid not attached to the water-soluble oligomer.
1. A compound having the structure:
wherein POLY is a poly(alkylene oxide) having a number of repeating monomers in the range of from 2 to 30.
2. The compound of claim 1 , wherein the poly(alkylene oxide) is a poly(ethylene oxide).
3. The compound of claim 1 , wherein the poly(alkylene oxide) has a number of repeating monomers in the range of from 2 to 10.
4. The compound of claim 1 , wherein the poly(alkylene oxide) includes an alkoxy or hydroxy end-capping moiety.
5. A composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
6. A composition comprising the compound of claim 1 , wherein the compound is present in a dosage form.